Original ArticleInternational Journal of Pharmaceutical InvestigationVol. 15 | Issue 4 | 2025 | pp. 1214–1226Open access
Evaluating the Neuroprotective and Antioxidant Effects of Orgaheal™ Ashwagandha with Valerian Root caplet in Oxidative Stress Models: In vitro study
- 1,
- 1*,
- 2,
- 1,
- 1,
- 1
- 1 Department of Clinical Research, Life Care Phyto Labs, Iyyappanthangal, Chennai, Tamil Nadu, INDIA.
- 2 Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, Porur, Chennai, Tamil Nadu, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Sudesh Raj
Department of Clinical Research, Life Care Phyto Labs, Iyyappanthangal, Chennai, Tamil Nadu, INDIA.
Email: sudesh@lifecarephytolabs.com
Copyright: © 2025 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2025
- Received:
- Jan 13, 2025
- Accepted:
- Jun 24, 2025
- DOI:
- 10.5530/ijpi.20250211
How to cite
Rajendran, Raj, S., Tejas, Jayakumar, Sneha, & Reethi. (2025). Evaluating the Neuroprotective and Antioxidant Effects of Orgaheal™ Ashwagandha with Valerian Root caplet in Oxidative Stress Models: In vitro study. International Journal of Pharmaceutical Investigation, 15(4), 1214–1226. https://doi.org/10.5530/ijpi.20250211
Abstract
Background
Ashwagandha (Withania somnifera), traditionally valued for enhancing stress resilience, is known for its neuroprotective and antioxidant effects. This study explores the Orgaheal™ Ashwagandha with Valerian Root, which includes Ashwagandha Root Powder, Ashwagandha Root Extract, and Organic Valerian Extract, for potential use in stress management and sleep enhancement.
Materials and Methods
This study investigated the antioxidant, neuroprotective, and adaptogenic effects in aqueous extract of Ashwagandha Formula (AAE) using in vitro assays. Antioxidant activity was assessed via DPPH, FRAP, and other radical scavenging assays. Neuroprotective effects were evaluated in SH-SY5Y neuroblastoma cells exposed to Dex-induced oxidative stress, measuring cell viability, ROS, apoptosis, and protein expressions (BDNF, pTrkB, CREB).
Results and Discussion
AAE demonstrated significant antioxidant activity, BChE inhibition (IC50: 4.8 mg/mL), and neuroprotective effects, likely due to withanolides and valerenic acid. These compounds reduced ROS, apoptosis, and restored antioxidant levels. In SH-SY5Y cells under Dex-induced oxidative stress, AAE improved cell viability and morphology, reversing Dex-induced suppression of BDNF, pTrkB, and CREB (all p<0.001), thereby enhancing cellular resilience.
Conclusion
Orgaheal™ Ashwagandha with Valerian Root, rich in withanolides and valerenic acid, offers potent antioxidant and neuroprotective effects, helping mitigate stress and enhance mental resilience.
Keywords
Subject
Article metadata
| Title | Evaluating the Neuroprotective and Antioxidant Effects of Orgaheal™ Ashwagandha with Valerian Root caplet in Oxidative Stress Models: In vitro study |
|---|---|
| Authors | Rajendran; Sudesh Raj; Tejas; Jayakumar; Sneha; Reethi |
| Affiliations | Department of Clinical Research, Life Care Phyto Labs, Iyyappanthangal, Chennai, Tamil Nadu, INDIA.; Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, Porur, Chennai, Tamil Nadu, INDIA. |
| Corresponding author | sudesh@lifecarephytolabs.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 15, Issue 4 (2025) |
Also in this issue
- A Short Review on Microglia in Neurodegenerative Disorders: An Overview of Natural Products in the Treatment of Neurodegenerative Disease by Targeting Arginase 1pp. 1065–1072
- Developments in Small Molecule Therapeutics Targeted Drug Delivery Systems for the Treatment of Breast Cancer: Present Approachespp. 1073–1085
- Mechanistic Modelling of Chromatographic Processes: Its Trends, Development, Challenges and Applicationspp. 1086–1095
- Advances in Collagen Biomaterials for Dental Applications: A Review from Biofabrication to Clinical Practicepp. 1096–1107
- Nosocomial Infections-An Overview of Prophylactic Approaches to Control VAPpp. 1108–1121